Prof. Rosa Amoroso completed the degree in Pharmaceutical Chemistry and Technology and the PhD in Organic Chemistry at University of Bologna. Nowadays she is Associate Professor of Medicinal Chemistry at University of Chieti, Italy. The scientific interests of Prof. Rosa Amoroso are mainly directed towards medicinal chemistry and the research topics are compunds active on Peroxisome proliferator-activated receptors (PPAR) and Nitric Oxide Synthase (NOS).
) Department of Pharmacy University of Chieti Chieti Italy
Dr. Bertho, Ph.D, is engineer of the French National Center of Research. He works in an interdisciplinary environment at Paris Descartes University, one of the main parisian medical university. Dr. Bertho was pioneering in France since 1993 in the field of ligand-based interaction studies by NMR in collaboration with several private companies and developed an automatic analysis of docking data (www.aupossom.com).
Dr. Bertho manages the human health project 'MetaboParis-Sante' identified in the French metabolomic network (RFMF). He is working to promote NMR in a clinical setting for the first time in France and to create the national center of reference in metabolomics by NMR.
) Laboratoire de Chimie et Biochimie Pharmacologiques et Toxicologiques Universite Paris Descartes Paris France
Dr. Clemente Bretti graduated in Chemistry with first class honours in July 2003 at University of Messina, Italy. He attended research doctorate in Chemical Sciences “Analytical chemistry” in the three-year course (2004-2007) at the University of Messina. Since Dec 30, 2008, he is a fixed-term Technician in the Department of “Scienze Chimiche” at the University of Messina. His research is mainly focused on the study of thermodynamics of solutions with particular reference to: (a) Study of the acid-base behavior and of the sequestering ability of different ligands of biological and environmental interest, and (b) Solubility and dependence on ionic strength. Dr. Bretti is a co-author of 46 scientific publications in various international journals.
) Department of “Scienze Chimiche” University of Messina Messina Italy
Dr. Stella Cascioferro graduated with an honors degree in pharmacy in 1999; she became a Ph.D. in Medicinal Chemistry from the University of Palermo
in 2004. The same year, she joined the Physical and Theoretical
Chemistry Laboratory, University of Oxford. Her research interests
include the design, synthesis, and biological evaluation of
heterocyclic compounds as antitumoral and antinfective agents.
Currently she is working in the Department STEBICEF (University of
Palermo, Italy). Dr. Stella Cascioferro is the author of 40 scientific
papers published in the peer reviewed international journals and she
also reviewed several journals in the field of medicinal chemistry.
) Department of Biological Sciences and Technologies Chemistry and Pharmaceuticals Section of Pharmaceutical Chemistry and Technologies University of Palermo Palermo Italy
Dr. Laurent Désaubry was promoted CNRS research director (corresponds to full professor) in 2014, and also became professor at Tianjin University of Science and Technology (TUST), China, in 2015. He has published 70 articles and 7 patents. His current main research interests concern the development of prohibitin ligands, non-peptide prokineticin receptor 1 agonists and new synthetic methodologies in organic synthesis (website: http://desaubry.u-strasbg.fr/).
) Laboratory of Innovation Therapeutics Pharmacological faculty CNRS University of Strasbourg Illkirch France
Dr. Mayhoub (PharmD) had a PhD degree (2012) in Medicinal Chemistry from Purdue University, USA. He was a postdoctoral fellow at University of Michigan (2013) and currently he is a faculty at Al-Azhar University and Zewail City for Science and Technology (Egypt). His main contributions in the field of Medicinal Chemistry included development of several cancer chemopreventives, aromatase inhibitors, and antiflaviviral agents (Dengue virus, West-Nile virus and HCV). He discovered phenylthiazoles as a new antibacterial class of compounds for treatment of notorious bacterial strains MRSA and VRSA.
) Department of Organic Chemistry College of Pharmacy Al-Azhar University Cairo Egypt
Dr. Prokai-Tatrai is a Professor of Pharmaceutical Sciences at UNT System College of Pharmacy at Fort Worth where she is an award winning researcher and pharmacy educator. Her primary research interest has been on innovative and multidisciplinary projects focusing on medicinal chemistry-driven drug design and delivery into the central nervous system. A best testimony of a very recent success of her lab has been published in Science Translational Medicine describing the very first brain-selective delivery of estrogens based on a unique bioprecursor prodrug approach. She has six issued US patents and has been an editorial board member of numerous journals and an academic editor of a successful special issue on neuroprotection.
) Department of Pharmaceutical Sciences University of North Texas Health Science Center Fort Worth, TX USA
Dr. Shailendra K. Saraf has done B. Pharm., M. Pharm., Ph.D., LL.B. He is a Professor of Pharmaceutical Chemistry and presently working as Director (Pharmacy), B.B.D.N.I.I.T., Lucknow, India. He has more than twenty six years of industrial, teaching and research experience. His major research interests include Synthetic Medicinal Chemistry, Phytopharmaceutical Chemistry and Nanochemistry. He has published more than 150 papers in national and international journals and conferences, and seventeen books/book chapters. He has delivered more than three dozen invited/plenary lectures and is a recipient of eight prestigious awards.
) Faculty of Pharmacy Babu Banarasi Das Northern India Institute of Technology (BBDNIIT) Lucknow India
Dr. Dianqing Sun is an Associate Professor of Pharmaceutical Sciences at the Daniel K. Inouye College of Pharmacy, University of Hawaii at Hilo. Before joining UH-Hilo, he was a Research Associate in the Department of Pharmaceutical Sciences of the College of Pharmacy, University of Tennessee Health Science Center. Dr. Sun received his Ph.D. from the University of Memphis, Organic Chemistry, and received his postdoctoral training in Medicinal Chemistry at the University of Tennessee. His Research is focused on the discovery and development of novel small molecule and natural product-inspired antibacterial, anticancer, and cancer chemopreventive agents, using classical organic synthesis and high-throughput chemistry approach, followed by traditional medicinal chemistry optimization of emerging lead compounds.
) Department of Pharmaceutical Sciences The Daniel K. Inouye College of Pharmacy University of Hawai'i at Hilo Hilo, HI USA
Antonio Vassallo obtained his master degree with laude on Pharmacy in 2002. November 2005 he obtained his Specialization in Hospital Pharmacy with laude. 2010 he obtained his Ph.D. discussing a doctoral thesis “Identification of new potential inhibitors of Hsp90, a promising target in cancer therapy”. He spent in 2006 and 2009 a traineeship of seven months at the Molecular Oncology Laboratory of Sigma-Tau (Rome). Since 2010, Assistant Professor at the University of Basilicata. Research objectives: The main field of research deals with studies of biologically active compounds isolated from food and medicinal plants and their drug delivery systems.
) Department of Science University of Basilicata Potenza Italy
G. Ascoli Molecular Neuroscience Department, George Mason University Krasnow Institute for Advanced Study Fairfax, VA USA
J.B. Chaires Department of Medicine, Health Sciences Center University of Louisville James Graham Brown Cancer Center Louisville, KY USA
J.-W. Chern School of Pharmacy College of Medicine National Taiwan University Taipei Taiwan
R. Eritja Department of Structural Biology Instituto de Biología Molecular de Centro de Investigación y Desarrollo Barcelona Spain
V.J. Hruby Department of Chemistry University of Arizona Tucson, AZ USA
M. Kassiou Faculty of Health Sciences University of Sydney Sydney Australia
T. Kietzmann Faculty of Chemistry/Biochemistry University of Kaiserslautern Kaiserslautern Germany
R. McGeary Chemistry Department (School of Molecular and Microbial Sciences) The University of Queensland Queensland Australia
Y. Okada Faculty of Pharmaceutical Sciences Kobe Gakuin University Kobe Japan
G. Perry Department of Biology The University of Texas at San Antonio College of Sciences San Antonio, TX USA
M. Poirot Sterol Metabolism and Therapeutic Innovations in Oncology Cancer Research Center of Toulouse University Toulouse Toulouse France
J. Sebastian Department of Infectious Diseases Center for Molecular Biology Laboratory Corporation of America Research Triangle Park, NC USA
T.W. Stone Institute of Biomedical & Life Sciences University of Glasgow Glasgow UK
K. Tekes Department of Pharmacodynamics Semmelweis University Budapest Hungary
L.I. Wiebe Division of Oncological Imaging, PET Centre Cross Cancer Institute Edmonton, AB Canada
Y.H. Wong Division of Life Science and the Biotechnology Research Institute The Hong Kong University of Science and Technology Kowloon Hong Kong
Dr. Alessandra Ammazzalorso obtained her PhD in Pharmaceutical Sciences from the University of Chieti (Italy) in 2001. Since 2004 she is Assistant Professor at Pharmacy Department of University of Chieti. Her research interests include the design, synthesis and biological evaluation of novel small molecules, mainly compounds targeting Peroxisome Proliferator-Activated Receptors, aromatase and nitric oxide synthase.
) Department of Pharmacy University “G.d’Annunzio” Chieti Italy
Emeritus Professor John Bremner holds a PhD in organic chemistry from the Australian National University, Canberra. He was formerly Professor of Organic Chemistry in the School of Chemistry, University of Wollongong, Wollongong, Australia. His research interests cover heterocyclic and medicinal chemistry, including the design and development of new anti-bacterial agents. He has over 220 scientific publications, and is on the Editorial Board of a number of journals.
) Department of Chemistry University of Wollongong Wollongong Australia
Dr. Francesco Paolo Busardò obtained his Bachelor’s Degree with Honors in Medicine and Surgery at the University of Palermo (Italy); winning the Prize for the Best Thesis. He did his MSc in Forensic Toxicology from the University of Glasgow (Scotland) and a PhD in Forensic Science from “Sapienza” University of Rome (Italy). He currently works as forensic toxicologist in “Sapienza” University of Rome. He focused most of his research on γ-Hydroxybutyric acid (GHB) pharmacology, toxicology and analytical aspects, publishing more than 20 papers in this field. He is author of about 90 papers with I.F., with a total I.F. higher than 250 and h-index of 10.
) Dep. of Anatomical, Histological, Forensic and Orthopaedic Sciences , Unit of Forensic Toxicology (UoFT), Sapienza University of Rome Rome Italy
Dr. Kalász is employed bythe Department of Pharmacology and Pharmacotherapy, Semmelweis University, Budapest, Hungary. He hasexperience in the isolation of natural products, pharmacokinetics and metabolism.
He worked at Yale University (New Haven, CT, USA and was a Visiting Professor in the Department of Pharmacology and Cell Biophysics, University of Cincinnati, Cincinnati, OH, USA.
Dr. Kalász holds various ranks of editorial boards at Journal of Chromatographic Science, Acta Chromatographica, Journal of Planar Chromatography, Current Chromatography, Current Medicinal Chemistry, Letters in Drug Design & Discovery, Medicinal Chemistry, Mini-Reviews in Medicinal Chemistry, The Open Medicinal Chemistry Journal, LC-GC Europe, LC-GC Asia-Pacific.
) Department of Pharmacology and Pharmacotherapy Semmelweis University Budapest Hungary
Sarel Malan obtained a Ph.D. in Pharmaceutical Chemistry, M.Sc. and B.Pharm. from the North-West University, Potchefstroom, South Africa. He is Professor and Director of the School of Pharmacy at the University of the Western Cape and is an Honorary Life Member of the Academy of Pharmaceutical Sciences and Fellow of the Pharmaceutical Society of South Africa. He has published more than 75 scientific papers and has authored or co-authored various papers and columns in professional journals, and conference contributions.
) Department of Pharmaceutical Chemistry School of Pharmacy University of the Western Cape Bellville South Africa
Dr. Ion Niculescu-Duvaz graduated at the Politechnical Institute in Bucharest, obtained a Ph.D. in Organic Chemistry (Cytostatic Hormones) at the Chemistry University ,Timisoara, Romania. He was the head of Anticancer Drug Department at the Oncological Institute in Bucharest and then the Head of Biochemistry Dept. at the same Institute.He was a holder of an Eleanor Roosevelt fellowship and moved in 1992, as senior scientist at The Institute of Cancer Research, Sutton, UK. He was also visiting Professor at the Faculty of Chemistry, in Le Mans, France.
He published142 scientific papers, 3 books, 13 chapters in monographies and authored 40 patents.
) CRC Centre for Cancer Therapeutics Institute of Cancer Research CR-UK laboratories Surrey UK
Dr. Khondaker Miraz Rahman is a Senior Lecturer in Medicinal Chemistry in the Institute of Pharmaceutical Science (IPS), King’s College London. His research activities are focused on the application of synthetic medicinal chemistry and chemical biology techniques to the design, synthesis and evaluation of novel drug-like chemical scaffolds as anti-cancer and anti-infective agents. He is an inventor of 6 patents and has more than 10 years’ research experience in medicinal chemistry and lead optimization in the anti-cancer and anti-infective areas. He has experience in both early- and late-stage drug discovery and translational research; co-founding Transcriptogen Ltd in 2013 and Femtogenix Ltd in 2015.
) Medicinal Chemistry Institute of Pharmaceutical Science King’s College London United Kingdom
Alessandro Serretti MD, PhD, Associate Professor of Psychiatry at Bologna University, Italy. Coordinator of a research unit active in clinical and genetic studies of major psychoses.
Author of more than 500 scientific papers in peer reviewed journals, one textbook of psychiatry and over 600 presentations at meetings. H-Index of 77.Reviewer or member of the editorial board for 170 journals and funding agencies.
) Department of Biomedical and NeuroMotor Science University of Bologna Institute of Psychiatry Bologna Italy
Since 2002, associate Professor of Pharmaceutical Chemistry.
The scientific activity, documented in 85 publications in international journals with high impact factors has been principally focused on the design and synthesis of small molecules as pharmacological tools and potential chemotherapeutic agents. She has a longstanding experience in the design and synthesis of heterocyclic compounds. The HIV represents her principle research interest but important results were recently achieved also in the anti-cytomegalovirus and anti-influenza fields, as well as derivatives as hepatitis C virus NS5B polymerase inhibitors. Other fields of interest are heterocyclic compounds as pump efflux inhibitors, and compounds active in Huntington disease.
) Department of Pharmaceutical Sciences University of Perugia Perugia Italy
Prof. Feng Yang was associate researcher of Brookhaven national lab in USA after the phD in biophysics at graduate school of Chinese academy of sciences. Nowadays he is primary investigator of State Key Laboratory for the Chemistry and Molecular Engineering of Medicinal Resources. His research interests include design anticancer metal drug based on the protein structure, protein-based drug delivery systems, and multi-drug combination therapy of cancer. Prof. Feng Yang is the author of about 40 papers published in the peer reviewed international journals and he also reviewed several journals in the fields of medicinal chemistry.
) Department of Chemistry and Pharmaceutical Science Guangxi Normal University Guangxi China
J. Baranowska-Kortylewicz Department of Radiation Oncology Bruce Henriksen Cancer Research Laboratories Omaha, NE USA
J. Chen Department of Medicinal Chemistry One Amgen Center Dr. Thousand Oaks, CA USA
A. Copani Department of Pharmaceutical Sciences University of Catania Catania Italy
A. Gueiffier Faculty of Pharmaceutical Sciences University of Tours Medicinal chemistry laboratory Tours France
Y. Ishikawa Cardiovascular Research Institute Yokohama City University Graduate School of Medicine Kanagawa Japan
C. Kerkhoff Institute of Experimental Dermatology University of Müenster Müenster Germany
G. Kouraklis Second Department of Propedeutic Surgery University of Athens School of Medicine Athens Greece
L.-J. Ming Department of Chemistry University of South Florida, Institute for Biomolecular Science Tampa, FL USA
P. Perjesi Department of Pharmaceutical Chemistry University of Pecs Institute of Pharmaceutical Chemistry Pécs Hungary
B. Pirotte Department of Medicinal Chemistry Pharmaceutical Chemistry Laboratory University of Liege Liege, Belgium
S. Rapposelli Department of Pharmaceutical Sciences University of Pisa Pisa Italy
T.J. Siahaan Department of Pharmaceutical Chemistry University of Kansas Lawrence, KS USA
C.T. Supuran Department Section of Pharmaceutical and Nutraceutical Sciences University of Florence Italy
J.A. Trapani Cancer Cell Death and Killer Cell Biology Laboratories Peter MacCallum Cancer Centre Victoria Australia
J.S. Williamson Department of Medicinal Chemistry University of Mississippi Oxford, MS USA
Dr. Nafees has joined MONASH University Malaysia (MUM) in September 2012. He obtained M.S. (Pharm) and PhD in Natural Products chemistry/Medicinal Chemistry from National Institute of Pharmaceutical Education and Research (NIPER), Mohali, India. He worked on total synthesis of natural products, synthesis of new chemical analogues for discovery of new anti-HIV agents based on natural products templates. Before joining MUM as lecturer, he was a Postdoctoral Research Fellow in Department of Medicinal Chemistry, School of Pharmaceutical Sciences, Universiti Sains Malaysia (USM) Penang. His current areas are computational based rational design of new drug candidates for HIV-1, dengue and other therapeutics.
) School of Pharmacy Monash University- Malaysia Campus Petaling Jaya Malaysia
Dr. Rajesh Kumar Singh received his Bachelor (2003) and Master degree (2005) in Pharmacy from Panjab University, Chandigarh. He completed his PhD (2008-2013) in Pharmaceutical Chemistry from Punjab Technical University, Jalandhar, and is in teaching profession since 2003. Dr. Singh’s major area of research interests include drug-design, polymer-drug conjugates, CNS active therapeutic agents and green chemistry approaches for chemical synthesis. He has to his credit more than 40 Research Papers, 46 Conference Abstracts, 1 Book and 6 Best Paper Awards. He is currently Editorial Board Member of 04 International Journals, has reviewed more than 40 International papers and got 6 research grants funded by government agencies.
) Pharmaceutical Chemistry Division Shivalik College of Pharmacy Punjab Technical University (Jalandhar) Nangal Rupnagar Punjab India
Dr. Osama M. Ahmed was granted Ph.D. (in 2000) in Physiology from Faculty of Science, Cairo University, Egypt. Dr. Ahmed is a professor of physiology at Faculty of Science, Beni-Suef University and Faculty of Oral and Dental Medicine, Nahda University, Beni-Suef, Egypt. His research interests are as follows: stem cell research, diabetes mellitus, maternal hypothyroidism and hyperthyroidism effects on fetuses and offspring, obesity, carcinogenesis, drug-induced toxicity, rheumatoid arthritis, hyperoxaluria, hyperhomocysteinemia, and assessment of medicinal plant and their constituents as well as novel synthetic organic compounds as protective, preventive and therapeutic remedies. He has authored/co-authored more than 90 publications, and has also written two book chapters.
) Zoology Department Beni-Suef University Beni-Suef Egypt
Dr. Jean-d’Amour K. Twibanire received his Ph.D. (2013) in Chemistry from Dalhousie University, Halifax, Canada. He was awarded the prestigious Natural Sciences and Engineering Research Council of Canada (NSERC) Postdoctoral Fellowship, which he held at CanAm Bioresearch Inc. in Winnipeg, Canada, focusing mainly on Medicinal Chemistry. He has published several papers in International Chemistry Journals and has also published outside of chemistry, for example “The United Nations Security Council: Imbalance of Power and the Need for Reform” was published in The International Journal of Political Science and Diplomacy, which is open access. Currently, Dr. Twibanire is with CanAm Bioresearch Inc. in Winnipeg, Canada, as a Research Scientist and Investigator.